Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer.

Abstract:

PURPOSE OF REVIEW:Differentiated thyroid cancer (DTC), with a rapidly increasing incidence is the most common endocrine malignancy, but with generally favorable survival. Total thyroidectomy with 'therapeutic' cervical lymph node dissection for involved lymph nodes is the standard of care. A more controversial topic is whether routine 'prophylactic' central lymph node dissection (CLND) in patients without evidence of lymph node metastasis should be performed in patients with DTC, as suggested by several recent management guidelines. RECENT FINDINGS:A number of retrospective studies suggest that regional lymph node metastases are associated with tumor recurrence and adverse survival. CLND is associated with a higher rate of postoperative athyroglobulinemia and may modify the indications for radioactive iodine treatment. Current guidelines from the American Thyroid Association suggest that prophylactic CLND may be performed for papillary thyroid cancer, especially for advanced tumors (T3 and T4). SUMMARY:Recent studies and the arguments for and against prophylactic CLND are reviewed. There is currently a trend toward more aggressive surgical therapy, including prophylactic CLND and avoidance of radioactive iodine treatment for DTC, when appropriate. Randomized prospective controlled trials are lacking at this point to determine the role of prophylactic CLND in the management of DTC.

journal_name

Curr Opin Oncol

authors

Carling T,Long WD 3rd,Udelsman R

doi

10.1097/CCO.0b013e328333ac97

subject

Has Abstract

pub_date

2010-01-01 00:00:00

pages

30-4

issue

1

eissn

1040-8746

issn

1531-703X

journal_volume

22

pub_type

杂志文章,评审
  • Approaches to relapse after allogeneic stem cell transplantation.

    abstract:PURPOSE OF REVIEW:Relapse has become the leading cause of death following allogeneic hematopoietic stem cell transplantation (HSCT). Despite improved understanding of the biology that underlies the graft-versus-leukemia/tumor effect the relapse rate did not decrease over the past 20 years. In general, prognosis is poor...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328342c6c8

    authors: Kröger N

    更新日期:2011-03-01 00:00:00

  • Metabolic regulation of Sirtuins upon fasting and the implication for cancer.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to highlight recent studies on mammalian sirtuins that coordinately regulate cellular metabolic homeostasis upon fasting and to summarize the beneficial effects of fasting on carcinogenesis and cancer therapy. RECENT FINDINGS:Recent studies have demonstrated that fasting...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000432527.49984.a3

    authors: Zhu Y,Yan Y,Gius DR,Vassilopoulos A

    更新日期:2013-11-01 00:00:00

  • Germ cell cancer.

    abstract::The publication of the proceedings of Fourth Workshop on Carcinoma in situ was an impressive leap in our understanding of the interaction between prenatal and postpubertal factors in the development of germ cell cancer as well as increased insight into the molecular events that are involved in the development of these...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199905000-00017

    authors: Oliver RT

    更新日期:1999-05-01 00:00:00

  • Advances in the treatment of elderly and frail patients with acute myeloid leukemia.

    abstract:PURPOSE OF REVIEW:Significant advances have been made in the treatment of younger patients with acute myeloid leukemia over the past 3 decades, but prognosis in the elderly has remained dismal, with median survival times of only a few months. Although a small percentage of older patients may be cured by standard chemot...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000124

    authors: Amadori S,Del Principe MI,Venditti A

    更新日期:2014-11-01 00:00:00

  • Reduced-intensity conditioning transplantation in myeloid malignancies.

    abstract::The development of non-myeloablative and reduced-intensity conditioning regimens has enabled older or medically infirm patients with myeloid malignancies to be treated with allogeneic hematopoietic cell transplantation (HCT). The regimens are sufficiently immunosuppressive to allow engraftment of allogeneic cells and ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000357467.45843.ba

    authors: Storb R

    更新日期:2009-06-01 00:00:00

  • An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma.

    abstract:PURPOSE OF REVIEW:Early trials of high-dose therapy with autologous stem cell transplantation in mantle cell lymphoma were discouraging, with no clear survival advantage attributable to the procedure. Most early series were plagued by small numbers, retrospective designs, and short follow-up. Also, until recently, allo...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200403000-00004

    authors: Jacobsen E,Freedman A

    更新日期:2004-03-01 00:00:00

  • Narrative ethics in the field of oncology.

    abstract:PURPOSE OF REVIEW:To evaluate the application of narrative within medical practice. Illness like cancer constitutes a biographical disruption that occurs several times during the disease, from diagnosis to complications and treatments. This review analyzes the interest of narrative ethics in medicine with a focus on ca...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000085

    authors: Lossignol D

    更新日期:2014-07-01 00:00:00

  • Sowing the seeds of cancer: telomeres and age-associated tumorigenesis.

    abstract:PURPOSE OF REVIEW:Advances in the health system and medical sciences are continuously pushing the barrier of life-expectancy. As a consequence, humans are being increasingly afflicted by age-associated diseases, such as cancer. The challenge now lies in understanding the mechanisms underlying ageing in order to reduce ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835b6358

    authors: Pereira B,Ferreira MG

    更新日期:2013-01-01 00:00:00

  • Cabozantinib as an emerging treatment for sarcoma.

    abstract:PURPOSE OF REVIEW:Sarcomas are a diverse group of rare solid tumors with limited treatment options for patients with advanced, inoperable disease. Cabozantinib is a tyrosine kinase inhibitor currently approved for advanced renal cell, hepatocellular, and medullary thyroid carcinoma. Cabozantinib has potent activity aga...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000644

    authors: Schöffski P,Blay JY,Ray-Coquard I

    更新日期:2020-07-01 00:00:00

  • Intrathoracic complications of malignancy and its treatment.

    abstract::Obstruction of the superior vena cava is seldom a true emergency and should not be treated without an adequate tissue diagnosis. For patients who are poor operative risks for invasive procedures, percutaneous biopsies of mediastinal masses under ultrasound guidance have resulted in a high diagnostic yield. Superior ve...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199503000-00010

    authors: Shepherd FA

    更新日期:1995-03-01 00:00:00

  • Advances in prostate cancer.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to highlight the most important developments in the diagnosis, prevention, and management of prostate cancer reported in the past year that have been published in the medical literature. RECENT FINDINGS:Recent research has yielded important insights into the effects of l...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200405000-00009

    authors: Ryan CJ,Small EJ

    更新日期:2004-05-01 00:00:00

  • Apply innovative technologies to explore cancer genome.

    abstract:PURPOSE OF REVIEW:Molecular genetic alterations characterize the development of human cancer. Recent advances in molecular genetic technology and the success of the human genome project have empowered investigators with new tools in dissecting the cancer genome for discovery of new cancer-associated genes. The purpose ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000147382.97085.e4

    authors: Shih IeM,Wang TL

    更新日期:2005-01-01 00:00:00

  • Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.

    abstract:PURPOSE OF REVIEW:Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) constitute a diverse group of neoplasms arising from the diffuse neuroendocrine cell system. During the last 2 years a new classification system, the WHO 2010, has come into clinical practice together with Tumor Nodes Metastases (TNM) staging and...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328353d7ba

    authors: Oberg K

    更新日期:2012-07-01 00:00:00

  • Atypical lipomatous tumor: molecular characterization.

    abstract:PURPOSE OF REVIEW:Atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDLs) are one of the more frequent mesenchymal neoplasms and are characterized by specific chromosome aberrations: supernumerary chromosome or giant marker chromosome or both. Extra copies of known oncogenes such as MDM2, CDK4, SAS, HMGA...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000127878.85125.53

    authors: Arrigoni G,Doglioni C

    更新日期:2004-07-01 00:00:00

  • Psychosocial aspects of breast cancer.

    abstract::Over the past year, several research areas have been noteworthy. This article discusses decision making related to breast cancer treatment, the effects of treatment on measures of psychological distress, and studies related to quality-of-life among breast cancer patients. In addition, an area of continued interest inv...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199311000-00008

    authors: Stefanek ME

    更新日期:1993-11-01 00:00:00

  • Treatment of adult acute leukemia.

    abstract::In 1996 progress has been made toward a better understanding of acute leukemias, their biology, the effects of different intensity or subtype-specific chemotherapy, and the contribution of bone marrow transplantation. In acute lymphoblastic leukemia, high-dose cytarabine in induction and in postremission treatment imp...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199701000-00004

    authors: Büchner T

    更新日期:1997-01-01 00:00:00

  • The emerging role of immunotherapy in advanced urothelial cancers.

    abstract:PURPOSE OF REVIEW:Recent Food and Drug Administration (FDA) approval of five new immune checkpoint inhibitors for the treatment of metastatic urothelial cancer represents the first major treatment breakthrough for this disease since the introduction of combination chemotherapy over 30 years ago. This review examines th...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000445

    authors: Tabayoyong W,Gao J

    更新日期:2018-05-01 00:00:00

  • Radiotherapy, hyperthermia, and phototherapy for central nervous system tumors.

    abstract::Many new modalities and increasing data have become available in the treatment of brain tumors. We will review the growing experience with newer treatment modalities such as brachytherapy, radiosurgery, hyperthermia, and photodynamic therapy. ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199206000-00015

    authors: Bahary JP,Larson DA

    更新日期:1992-06-01 00:00:00

  • Diagnostic radiology of head and neck oncology.

    abstract::The rapid development of computed tomography and magnetic resonance imaging has resulted in numerous applications of these modalities in head and neck oncology. In the past year further refinements in diagnostic capabilities have been obtained in magnetic resonance imaging. Computed tomography is rapidly being replace...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199106000-00011

    authors: Castelijns JA

    更新日期:1991-06-01 00:00:00

  • Bone marrow transplantation for chronic myelogenous leukemia.

    abstract::Chronic myelogenous leukemia (CML) is a hematologic malignancy characterized by an initial chronic phase of expanded clonal myelopoiesis followed by inevitable progression to accelerated phase and finally to fatal blast crisis. Although interferon therapy results in hematologic control of disease in most patients and ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199803000-00003

    authors: Enright H,McGlave P

    更新日期:1998-03-01 00:00:00

  • Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?

    abstract:PURPOSE OF REVIEW:Prevention of infectious complications of chemotherapy-induced granulocytopenia is a major issue in preventive medicine, as febrile neutropenia is still associated with an overall 10% mortality and extensive morbidity and cost. RECENT FINDINGS:The prescription of granulocyte colony-stimulating factor...

    journal_title:Current opinion in oncology

    pub_type: 社论,评审

    doi:10.1097/CCO.0b013e32832c9651

    authors: Klastersky J,Awada A,Aoun M,Paesmans M

    更新日期:2009-07-01 00:00:00

  • Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer.

    abstract::Tyrosine kinase (type 1) growth factor receptors include the erbB family. These cell surface receptors were discovered in the context of cellular transformation and have subsequently been found to be overexpressed in many types of human cancer. Cumulative evidence suggests that upregulation of the most well-characteri...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200105000-00007

    authors: Lango MN,Shin DM,Grandis JR

    更新日期:2001-05-01 00:00:00

  • The management of small-cell carcinomas of the gynecologic tract.

    abstract:PURPOSE OF REVIEW:Small-cell carcinomas of the gynecologic tract are aggressive malignancies that can be misdiagnosed or inappropriately managed. This review provides a summary of current literature that will help the clinician to correctly diagnose and treat patients with small-cell carcinomas of the cervix, ovary, ut...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3283565ed6

    authors: Cohen JG,Chan JK,Kapp DS

    更新日期:2012-09-01 00:00:00

  • The next-generation ALK inhibitors.

    abstract:PURPOSE OF REVIEW:Crizotinib now is accepted as the standard first-line treatment of ALK-rearranged lung adenocarcinomas. To overcome the problem of crizotinib resistance, second-generation ALK inhibitors are in development. The aim of this review is to give an overview on the mechanisms behind crizotinib resistance an...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000165

    authors: Pall G

    更新日期:2015-03-01 00:00:00

  • The type II transforming growth factor-beta receptor as a tumor-suppressor gene.

    abstract::Recent work has shown that: 1) loss of transforming growth factor-beta response is associated with malignant progression, 2) maintenance of autocrine negative transforming growth factor-beta activity is a key impediment to malignant progression, and 3) the major mechanism for loss of RII expression in replication erro...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199601000-00009

    authors: Brattain MG,Markowitz SD,Willson JK

    更新日期:1996-01-01 00:00:00

  • Implications of the sentinel lymph node procedure for local and systemic adjuvant treatment.

    abstract:PURPOSE OF REVIEW:The objective of the sentinel lymph node procedure in breast cancer is to perform an accurate axillary staging and provide good local control, while sparing the patients the morbidity of an axillary lymph node dissection. Since its routine clinical use, questions were raised concerning the implication...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000183542.63675.66

    authors: Smeets A,Christiaens MR

    更新日期:2005-11-01 00:00:00

  • Recent advances in brain tumor molecular biology.

    abstract::Work in the field of molecular neuro-oncology has evolved from a purely descriptive catalogue of regional mutations to the implication of specific genes in the malignant process. Reverse genetic strategies have resulted in the cloning of the neurofibromatosis-1 and neurofibromatosis-2 genes, the molecular physiology o...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199405000-00002

    authors: Mikkelsen T

    更新日期:1994-05-01 00:00:00

  • Testicular cancer.

    abstract::The rising rate of germ cell cancer of the testis over the past decade has been demonstrated to be occurring predominantly in the younger age group (15 to 19 years) in association with earlier onset of puberty and earlier onset of regular sexual activity. Chemicals and viruses, with their atrophogenic effect, remain t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199605000-00015

    authors: Oliver RT

    更新日期:1996-05-01 00:00:00

  • Advances in the diagnosis and management of thyroid neoplasms.

    abstract::Thyroid cancers are still the most common endocrine cancers. They are dominated by well-differentiated carcinomas, including papillary carcinoma, follicular carcinoma, and medullary thyroid carcinoma. Diagnosis is based on fine-needle aspiration cytologic examination. Recently, reverse transcription polymerase chain r...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200001000-00009

    authors: Bi J,Lu B

    更新日期:2000-01-01 00:00:00

  • Imatinib in advanced gastrointestinal stromal tumour: when is 800 mg the correct dose?

    abstract:PURPOSE OF REVIEW:Gastrointestinal stromal tumour patients with exon 9 KIT mutations have a worse outcome, but progression-free survival is improved by treatment with imatinib 800 mg daily. This review looks at the evidence and asks whether this should be standard treatment from diagnosis. RECENT FINDINGS:The phase II...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328302ed96

    authors: Judson I

    更新日期:2008-07-01 00:00:00